NCT00174278View on ClinicalTrials.gov

Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary

PHASE3CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

February 28, 1997

Study Completion Date

October 31, 2006

Conditions
Growth Hormone DeficiencyGrowth Retardation
Interventions
DRUG

Somatropin

Trial Locations (1)

Unknown

Pfizer Investigational Site, Paris

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00174278 - Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary | Biotech Hunter | Biotech Hunter